Universitätsklinik Erlangen

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma1 trial
• Neuroendocrine tumours1 trial
• Pancreatic cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Exelixis1 trial
• GBG Forschungs GmbH1 trial
• Prof. Dr. Hartmut Goldschmidt1 trial

Running trials

• Recruiting

  Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  NCT06943755· Phase 2/3· Exelixis· Source

  Contact: Exelixis Clinical Trials

• Recruiting

  GMMG Multiple Myeloma Registry

  NCT07111884· Prof. Dr. Hartmut Goldschmidt· Source

  Contact: Heidi Waibel, Dr.

• Active, not recruiting

  Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

  NCT04595565· Phase 3· GBG Forschungs GmbH· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma1 recruiting
• Neuroendocrine tumours1 recruiting
• Pancreatic cancer1 recruiting